| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;74:37-42
© 2002 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
* Address reprint request to Dr Craver, The Emory Clinic, 1365 Clifton Rd, Atlanta, GA 30322 USA
e-mail: christy_jenkins{at}emoryhealthcare.org
Presented at the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2002.
Background. Reports are sparse describing heart valve replacement in patients with end-stage renal disease. This review assesses a 15-year experience and outcomes after valve replacement in patients on chronic preoperative renal dialysis.
Methods. A computerized database, hospital records, and telephone contact provided outcome data for patients on chronic dialysis undergoing valve replacement between March 22, 1985, and October 13, 2000, in two hospitals.
Results. Seventy-two patients underwent 95 valve procedures (74 operations). Ages ranged from 23 years to 84 years (mean, 57 years). Fifty-five aortic, 30 mitral, and 3 tricuspid valve replacements and 7 valvuloplasties were performed. Six of the 74 procedures were reoperative valve replacements. In the 46 patients with reliable long-term (greater than 30 days) follow-up data, significant bleeding or stroke was documented in 17 of 34 patients with a mechanical valve and 1 of 12 patients with a bioprosthetic valve. Overall survival (including two operative deaths) was 72.8% at 3 months, 65.4% at 6 months, 60.5% at 1 year, 39.8% at 2 years, 28.5% at 3 years, and 15.9% at 6 years (Kaplan-Meier). Type of valve implanted did not influence early and late survival.
Conclusions. In this series of patients on chronic dialysis, survival appears to justify valve replacement. However, the sixfold higher incidence of late bleeding or stroke in patients on dialysis with a mechanical valve requiring warfarin suggests that bioprosthetic valves are the valve substitute of choice in patients on chronic dialysis.
This article has been cited by other articles:
|
|
 |
|
  F. Filsoufi, J. Chikwe, J. G. Castillo, P. B. Rahmanian, J. Vassalotti, and D. H. Adams Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3613 - 3621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kato, K. Tajima, S. Terasawa, K. Tanaka, A. Usui, and Y. Ueda Results of Isolated Valve Replacement in Hemodialysis Patients Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): 386 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Boku, M. Masuda, M. Eto, T. Nishida, S. Morita, and R. Tominaga Risk Evaluation and Midterm Outcome of Cardiac Surgery in Patients on Dialysis Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): 19 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Chan, W.R. E. Jamieson, A. G. Fleisher, D. Denmark, F. Chan, and E. Germann Valve Replacement Surgery in End-Stage Renal Failure: Mechanical Prostheses Versus Bioprostheses. Ann. Thorac. Surg., March 1, 2006; 81(3): 857 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cooper, W. Brinkman, R. J. Petersen, and R. A. Guyton Impact of renal disease in cardiovascular surgery: emphasis on the African-American patient Ann. Thorac. Surg., October 1, 2003; 76(4): S1370 - 1376. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
